Drugie życie psychodelików
Kosmos August 8, 2024 Krystyna Gołembiowska, K. Kamińska
Classic psychedelics such as psilocybin, mescaline, DMT, and LSD alter consciousness, perception, and produce hallucinations through serotonergic pharmacodynamic effects. These compounds profoundly affect neuroplasticity—altering neuronal structure and function. Their psychoplastogenic properties suggest potential for treating depression, neurodegenerative disorders like Alzheimer's disease, recovery after stroke, and schizophrenia. The role of microdosing, defined as 10% of the dose that elicits psychedelic effects, requires extensive further investigation.